FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a means correcting cholinergic disorders of mnestic processes. Use of diterpene alkaloid songorine as a means of correcting the cholinergic disorders of mnestic processes.
EFFECT: above-described agent is effective for correcting cholinergic disorders of mnestic processes.
1 cl, 1 dwg, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING ANXIOLYTIC ACTIVITY | 2015 |
|
RU2571286C1 |
ACTIVE INGREDIENT OF MEDICINAL AGENT WITH CEREBROPROTECTIVE, ANTIHYPOXIC AND ANTIAMNESTIC ACTIVITY FOR TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND METHOD FOR PREPARING THE SAME | 2023 |
|
RU2821508C1 |
METHOD FOR TREATING AFFECTED AMNESTIC FUNCTIONS | 2004 |
|
RU2268726C2 |
AGENT SHOWING PROPERTIES OF COGNITIVE FUNCTION ACTIVATOR (VERSIONS) | 2010 |
|
RU2438672C1 |
CEREBROPROTECTIVE AGENT | 2012 |
|
RU2501562C1 |
QUINAZOLINE DERIVATIVES, POSSESSING NOOTROPIC AND ANTIHYPOXIC ACTIVITY | 2012 |
|
RU2507198C1 |
PHARMACEUTICALLY ACCEPTABLE ACETYL-(D-LYS)-LYS-ARG-ARG-AMIDE PEPTIDE SALTS | 2021 |
|
RU2763136C1 |
NEUROTROPIC AGENT WITH ANTIOXIDANT, ANTIHYPOXIC, NEUROPROTECTOR, ANTIAMNESIC AND ANTI-MOTION SICKNESS ACTIVITY AND CAPABLE OF ENHANCING COGNITIVE FUNCTIONS | 2008 |
|
RU2394816C1 |
REMEDY POSSESSING NOOTROPIC AND ADAPTATION PROPERTIES AND METHOD FOR PRODUCING THE REMEDY | 1996 |
|
RU2130314C1 |
AGENT POSSESSING ANXIOLYTIC, NOOTROPIC, ANTICONVULSANT, ANTIDEPRESSIVE, CEREBRO-PROTECTING ACTIVITY AND ABILITY TO NORMALISE TRANSFER PROCESSES IN BRAIN SYNAPSES | 2007 |
|
RU2335293C1 |
Authors
Dates
2018-09-05—Published
2017-07-10—Filed